<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="365287">
  <stage>Registered</stage>
  <submitdate>16/12/2013</submitdate>
  <approvaldate>9/01/2014</approvaldate>
  <actrnumber>ACTRN12614000025639</actrnumber>
  <trial_identification>
    <studytitle>Sequential letrozole and human menopausal gonadotropins (HMG) : The effect of a novel super ovulation protocol on pregnancy rate in polycystic ovarian syndrome patients undergoing intracytoplasmic sperm injection. Randomized Controlled Trial  </studytitle>
    <scientifictitle>Sequential administration of letrozole and Human Menopausal gonadotropins (HMG) improves the pregnancy rate in polycystic ovarian syndrome ( PCOS) patients  treated with intracytoplasmic sperm injection ( ICSI )  a randomized controlled trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>No</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>polycystic ovary syndrome </healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fertility including in vitro fertilisation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Induction of ovulation  will be done by  letrozole tablets 5 mg  mg /day  from day 2  to day 6 of the participant's menstrual cycle then human menopausal gonadotropins ( HMG ) ampoules (fostimon ;IBSA) ( 150-225 IU /day ) will be given intramuscular  according to  patients response  started from day 7 of menstrual follow  till the day of  human chorionic gonadotropin (HCG) -which is a hormone similar to endogenous lutienizing hormone to trigger ovulation-in a dose of 10000 iu intramuscular when the dominant follicle reaches 17 mm .
ovum pick up for Intracytoplasmic sperm injection (ICSI ) will be done 34-36 hours after HCG adminstration. </interventions>
    <comparator>Induction of ovulation will be  done  by HMG ampoules(fostimon ; IBSA) alone using a dose of 150- 225 IU / day intramuscular injection and tailored according to patients response starting from the second  day of the natural or induced menstrual flow till the day of  human chorionic gonadotropin (HCG) that will be given in a dose of 10000 iu intramuscular when the dominant follicle reaches 17 mm .
ovum pick up for ICSI will be done 34-36 hours after HCG adminstration.          </comparator>
    <control>Active</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome> the number of oocytes obtained through ovum pickup by transvaginal ultrasound guided  aspiration through identification of oocyte under microscopy after ovum pickup </outcome>
      <timepoint>Approximately 34 - 36 hours after HCG administration</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome> the number of mature oocytes through assessment of maturity criteria under microscopy using first polar body assessment </outcome>
      <timepoint> 1-2 hours after ovum pick up</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Gonadotropins dosage and duration of induction ( composite outcome ) dated from the start of ovulation induction until the day of HCG and from number of days we will calculate the total dose of gonadotropins by muliplying the dose per day by the number of days .</outcome>
      <timepoint>from the start of induction to be monitored very 2-3 days until the day of HCG administration </timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome> fertilization rate ( the number fertilized oocytes divided by the number of injected mature oocytes)</outcome>
      <timepoint>18-24 hours after oocyte pickup</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>number of embryos assessed under microscopy </outcome>
      <timepoint>at day three of ovum pickup</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>grades of embryos  through scoring of embryos using the fragmentation percentage , equality of the cells and number of cells in embryos (8 cells at day 3 )</outcome>
      <timepoint>at day 3 post ovum pickup</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>  chemical pregnancy rates by measuring serum  quantitative HCG level </outcome>
      <timepoint>14 days after oocyte pickup (as mentioned before oocyte pickup done after 34-36 of  HCG adminstration)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>clinical pregnancy rate through visualization of cardiac pulsation</outcome>
      <timepoint> 6-8 weeks after oocyte pickup(as mentioned before oocyte pickup done after 34-36 og HCG adminstration)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>PCOS complaining of infertility 
age between 20-35 years.
normal semen analysis according to WHO criteria </inclusivecriteria>
    <inclusiveminage>20</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>35</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>female with a previous history of pelvic surgery 
 endometriosi.
 females with a previous history of failed ICSI                                                                             </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>centeral randomization by computer</concealment>
    <sequence>Simple randomisation using a randomisation table created by computer software (i.e. computerised sequence generation)</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>by calculating the power of the study statistically beside the estimation of number of cases seen clinically .</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>15/01/2014</anticipatedstartdate>
    <actualstartdate>15/01/2014</actualstartdate>
    <anticipatedenddate>16/04/2014</anticipatedenddate>
    <actualenddate>8/01/2016</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize>40</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Egypt</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>alexandria university , faculty of medicine </primarysponsorname>
    <primarysponsoraddress>22 elgeish street , elshatby  
Alexandria , egypt 
21526 </primarysponsoraddress>
    <primarysponsorcountry>Egypt</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress>port saeed street alexandria egypt  
Elshatby maternity university hospital 
21526</fundingaddress>
      <fundingcountry>Egypt</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>a new induction protocol for polycyctic ovary syndrome patients complaining of inability to concieve that hopefully will lead to improvement of pregnancy rate </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>ethical committe , faculty of medicine ,alexandria university </ethicname>
      <ethicaddress>Champollion Street

El-Khartoum Square

Azarita Medical Campus  alexandria egypt 
21526 </ethicaddress>
      <ethicapprovaldate>27/11/2013</ethicapprovaldate>
      <hrec>IRB  00007555-fwa no : 00015712</hrec>
      <ethicsubmitdate />
      <ethiccountry>Egypt</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street 
alexandria Egypt 
21526 </address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street 
alexandria Egypt 
21526 </address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street 
alexandria Egypt 
21526 </address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>ahmed fawzy galal</name>
      <address>Elshatby maternity university hospital 
port saeed street 
alexandria Egypt 
21526 </address>
      <phone>+201222286962</phone>
      <fax />
      <email>galal_af@yahoo.com</email>
      <country>Egypt</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>